MedTrace Logo

Best Possible Self-Tech for Middle Schoolers

NCT07540819 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-05-20

No results posted yet for this study

Summary

The goal of this pilot clinical trial is to learn if a single-session writing exercise (i.e., Best Possible Self-Tech) can improve positive affect and prosocial technology use in a community sample of eighth graders. The main questions it aims to answer are:

1. Can the the Best Possible Self-Tech (BPS-Tech) intervention be feasibly and acceptably delivered in classrooms?
2. What are the associations between textual features of BPS- Tech entries (e.g., length, vividness, positive tone) and post-intervention positive affect?
3. How do participants describe their future prosocial online behavior ("doing good"), engagement with prosocial content ("seeing good") and associated positive emotions ("feeling good") in the BPS-Tech writing exercise?

Participants will participate in the BPS-Tech exercise during class time and respond to surveys about their prosocial technology use and positive affect.

Conditions

  • Technology Use
  • Positive Affect

Interventions

BEHAVIORAL

Best Possible Self-Tech

The BPS is a structured writing exercise (i.e., 10 minutes) designed to help individuals imagine the details about their future selves assuming things have gone as well as they possibly could. In the technology-related adaptation, participants are directed to imagine how their best possible self would utilize technology. The goal of the intervention is to increase positive thinking and mindful engagement with technology by helping adolescents envision and articulate optimistic future possibilities for their digital lives.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Oregon

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-27
Primary Completion
2026-06-01
Completion
2026-09-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07540819 on ClinicalTrials.gov